Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.

Wadden, Thomas A et al.·Nature medicine·2023·
RPEP-075042023RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.
Published In:
Nature medicine, 29(11), 2909-2918 (2023)
Database ID:
RPEP-07504

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-07504·https://rethinkpeptides.com/research/RPEP-07504

APA

Wadden, Thomas A; Chao, Ariana M; Machineni, Sriram; Kushner, Robert; Ard, Jamy; Srivastava, Gitanjali; Halpern, Bruno; Zhang, Shuyu; Chen, Jiaxun; Bunck, Mathijs C; Ahmad, Nadia N; Forrester, Tammy. (2023). Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.. Nature medicine, 29(11), 2909-2918. https://doi.org/10.1038/s41591-023-02597-w

MLA

Wadden, Thomas A, et al. "Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial.." Nature medicine, 2023. https://doi.org/10.1038/s41591-023-02597-w

RethinkPeptides

RethinkPeptides Research Database. "Tirzepatide after intensive lifestyle intervention in adults..." RPEP-07504. Retrieved from https://rethinkpeptides.com/research/wadden-2023-tirzepatide-after-intensive-lifestyle

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.